Total Payments
$13,412
2024 Payments
$1,310
Companies
59
Transactions
707
Medicare Patients
2,814
Medicare Billing
$344,505
Payment Breakdown by Category
Food & Beverage$13,044 (97.3%)
Education$249.99 (1.9%)
Other$118.55 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,044 | 690 | 97.3% |
| Education | $249.99 | 11 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $118.55 | 6 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,666 | 109 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $968.24 | 34 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $886.83 | 52 | $0 (2023) |
| UCB, Inc. | $875.16 | 32 | $0 (2024) |
| Allergan, Inc. | $873.17 | 59 | $0 (2022) |
| Biogen, Inc. | $837.91 | 50 | $0 (2024) |
| Lilly USA, LLC | $596.47 | 27 | $0 (2024) |
| Amgen Inc. | $509.81 | 28 | $0 (2024) |
| EMD Serono, Inc. | $481.40 | 24 | $0 (2024) |
| CSL Behring | $468.22 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,310 | 64 | ABBVIE INC. ($320.90) |
| 2023 | $1,641 | 74 | ABBVIE INC. ($426.09) |
| 2022 | $1,464 | 79 | ABBVIE INC. ($384.83) |
| 2021 | $1,280 | 72 | AbbVie Inc. ($501.56) |
| 2020 | $1,010 | 59 | Allergan, Inc. ($274.02) |
| 2019 | $2,159 | 124 | Novartis Pharmaceuticals Corporation ($387.36) |
| 2018 | $795.64 | 37 | UCB, Inc. ($115.10) |
| 2017 | $3,753 | 198 | Teva Pharmaceuticals USA, Inc. ($869.16) |
All Payment Transactions
707 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Neuroscience | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/27/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: Immunology | ||||||
| 11/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.11 | General |
| 11/06/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: AMANTADINE | ||||||
| 11/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/04/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/16/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Analgesic | ||||||
| 10/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Neurology | ||||||
| 10/02/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.27 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/17/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Neuroscience | ||||||
| 09/09/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/29/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 661 | 803 | $177,511 | $75,509 |
| 2022 | 11 | 671 | 843 | $185,409 | $82,766 |
| 2021 | 12 | 718 | 955 | $204,842 | $90,978 |
| 2020 | 14 | 764 | 982 | $196,416 | $95,252 |
Total Patients
2,814
Total Services
3,583
Medicare Billing
$344,505
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 267 | $48,060 | $26,089 | 54.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 158 | 158 | $42,660 | $19,918 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 132 | $17,820 | $9,572 | 53.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 59 | $23,010 | $7,928 | 34.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 61 | $9,150 | $3,939 | 43.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 75 | 76 | $28,500 | $3,558 | 12.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 15 | 27 | $3,861 | $2,374 | 61.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,450 | $2,130 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 338 | $60,840 | $33,490 | 55.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 179 | 179 | $46,560 | $23,616 | 50.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 32 | $12,480 | $5,027 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 63 | $8,910 | $4,486 | 50.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 69 | $10,350 | $3,983 | 38.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 69 | 74 | $27,750 | $3,487 | 12.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 16 | 27 | $3,861 | $2,501 | 64.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $4,000 | $2,127 | 53.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 12 | 12 | $3,288 | $1,493 | 45.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 17 | $3,570 | $1,406 | 39.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $3,800 | $1,149 | 30.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 153 | 253 | $44,100 | $24,503 | 55.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 144 | 144 | $34,560 | $19,163 | 55.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 82 | 82 | $31,980 | $13,820 | 43.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 82 | 168 | $25,200 | $10,103 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 82 | $11,175 | $6,069 | 54.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 32 | 46 | $6,578 | $4,287 | 65.2% |
About Dr. Monquen Huang, M.D
Dr. Monquen Huang, M.D is a Neurology healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2009. The National Provider Identifier (NPI) number assigned to this provider is 1477782035.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Monquen Huang, M.D has received a total of $13,412 in payments from pharmaceutical and medical device companies, with $1,310 received in 2024. These payments were reported across 707 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($13,044).
As a Medicare-enrolled provider, Huang has provided services to 2,814 Medicare beneficiaries, totaling 3,583 services with total Medicare billing of $344,505. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Torrance, CA
- Active Since 07/03/2009
- Last Updated 03/12/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1477782035
Products in Payments
- UBRELVY (Drug) $904.56
- COPAXONE (Drug) $692.66
- BOTOX (Biological) $552.21
- QULIPTA (Drug) $508.13
- Hizentra (Biological) $468.22
- Aimovig (Biological) $441.91
- Vimpat (Drug) $440.44
- TYSABRI (Biological) $403.36
- EMGALITY (Drug) $359.88
- AIMOVIG (Biological) $357.03
- APTIOM (Drug) $355.77
- Briviact (Drug) $323.67
- NUPLAZID (Drug) $312.62
- RYTARY (Drug) $305.73
- NAMZARIC (Drug) $299.37
- AUBAGIO (Drug) $224.84
- TROKENDI XR (Drug) $220.14
- Rebif (Biological) $194.25
- Xadago (Drug) $186.69
- GILENYA (Drug) $167.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Torrance
Dr. Jason Tarpley, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $21,061
Neurology $21,061
Dr. Han Lee, M.d, M.D
Neurology — Payments: $20,140
Neurology $20,140
Jeffrey Kim, M.d, M.D
Neurology — Payments: $11,411
Neurology $11,411
Ben Tseng, M.d, M.D
Neurology — Payments: $10,277
Neurology $10,277
Kevin Kapur, M.d, M.D
Neurology — Payments: $5,145
Neurology $5,145
Dr. David Edelman, Md, MD
Neurology — Payments: $4,394
Neurology $4,394